Glofitamab
Product Specifications
CAS Number
2229047-91-8
Target
Integrin, Immunology/Inflammation related, Others
Related Pathways
Others, Cytoskeletal Signaling, Immunology/Inflammation
Purity
0.984
Bioactivity
Glofitamab (RO7082859) is a novel bivalent antibody directed against CD20-binding T cells.Glofitamab promotes T cell proliferation and activation and tumor cell killing by binding to CD20 on malignant cells.Glofitamab can be used for the palliation of relapsed or refractory B-cell lymphomas.
Shipping Conditions
Ice Packs
Storage Temperature
-20°C
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
O7030-40A 1 mg
Opioid Receptor 1, mu, aa384-398 Control Peptide (MOR1)
Sign In for Pricing
View Details 